Our Perspectives

systematic literature review

3 min read

Breaking Down Barriers in Diabetes Care During Diabetes Awareness Month

November is Diabetes Awareness Month, a dedicated time to spotlight a condition that affects over 400 million people worldwide. This month serves as...

Read More

3 min read

Exploring Alternative Payment Models in Healthcare

For years, the standard method of payment to physicians has been “fee-for-service” (FFS). This method was introduced in the 1930s and refers to...

Read More

2 min read

Mind Medicine: The Resurgence of Psychedelic Drugs in Mental Health Care

For hundreds of years, psychedelic drugs have been praised for their medicinal benefits and mind-altering effects. Known also as hallucinogenic,...

Read More

6 min read

Understanding the Alzheimer's Research and Treatment Landscape: From Challenges to Hope

In the book, “Outlive,” Peter Attia refers to neurodegenerative diseases, such as Alzheimer’s and dementia, as one of the “Four Horsemen” of chronic...

Read More

4 min read

Telehealth’s Evolution Beyond Pandemic Response: A Comprehensive Outlook

The COVID-19 pandemic acted as a catalyst for the widespread adoption of telehealth. Initially driven by necessity, virtual care rapidly became an...

Read More

3 min read

Charting the Course: The Rise of Digital Therapeutics in Healthcare

Technological innovation has had an immense impact on healthcare delivery. Novel medical devices and cutting-edge pharmaceuticals continue to...

Read More

3 min read

Mark Cuban’s Cost Plus Drugs: A Game-Changer in Health Accessibility

The escalating cost of prescription drugs has become a pressing concern for patients, healthcare providers, and policymakers alike. In this landscape...

Read More

3 min read

Securing the Future: Navigating Challenges and Opportunities in Medicare

Medicare Advantage has been facing criticism for its administrative and financial delays, and an increasing number of hospitals are scrapping their...

Read More

2 min read

Diversifying Clinical Trials: Navigating the FDA's Roadmap for Inclusive Research

In April 2022, the FDA released draft guidance with recommendations for drug developers and clinical trial researchers. The guidance highlights gaps...

Read More